Cases & Deals

  • Home
  • Practices
  • PRP Diagnostic Imaging and PRP Group Investments sold to Crescent Capital Partners

Share

PRP Diagnostic Imaging and PRP Group Investments sold to Crescent Capital Partners

June 2020

Client(s) PRP Diagnostic Imaging (PRP) and PRP Group Investments (PRPG)

Jones Day advised PRP Diagnostic Imaging (PRP) and PRP Group Investments (PRPG) on the sale of PRP to private equity fund Crescent Capital Partners (Crescent). Crescent signed the deal to acquire 100% of PRP on June 9, 2020, valuing the company at AUD $440 million.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.